By NewsDesk  @infectiousdiseasenews New research published by The Pew Charitable Trusts, University of Utah, and Infectious Diseases Society of America showed that in 2017, infections caused by six antibiotic-resistant...

Achaogen, Inc.,  a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative infections, announced this week that the U.S. Food and...

Every year, millions of travelers visit countries with poor hygiene, and approximately one third of them return home carrying antibiotic-resistant ESBL intestinal bacteria. Most of them remain unaware...

Recent research has revealed the worldwide spread of a very serious antibiotic resistance to a “last line” drug, colistin, which is linked to use in agriculture. Infectious disease specialist...

The number of infections caused by highly antibiotic-resistant extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli (E. coli) bacteria is increasing in community hospitals, a setting in which...